2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 46.288 | 13.748 | 150.859 | 223.441 | 381.668 | 311.853 | 267.158 | 305.004 | 476.934 | 382.874 |
Total Income - EUR | 49.260 | 96.584 | 164.504 | 283.735 | 436.227 | 333.289 | 302.216 | 339.553 | 521.225 | 522.656 |
Total Expenses - EUR | 23.368 | 73.925 | 145.989 | 167.259 | 301.118 | 305.710 | 213.341 | 313.992 | 430.470 | 478.010 |
Gross Profit/Loss - EUR | 25.892 | 22.659 | 18.515 | 116.476 | 135.109 | 27.578 | 88.875 | 25.561 | 90.755 | 44.646 |
Net Profit/Loss - EUR | 24.138 | 22.246 | 15.344 | 110.823 | 132.586 | 26.221 | 88.037 | 23.480 | 86.829 | 41.740 |
Employees | 0 | 0 | 0 | 1 | 2 | 2 | 2 | 0 | 2 | 4 |
Check the financial reports for the company - Biosab Timişoara Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 6.838 | 9.177 | 201.185 | 228.472 | 372.072 | 390.665 | 346.961 | 331.387 | 441.238 | 473.255 |
Current Assets | 37.646 | 106.610 | 51.341 | 116.923 | 305.194 | 246.356 | 344.450 | 436.039 | 567.013 | 681.105 |
Inventories | 5.525 | 45.339 | 27.514 | 23.637 | 39.443 | 77.319 | 154.226 | 199.305 | 295.358 | 415.747 |
Receivables | 1.066 | 47.858 | 8.979 | 85.592 | 261.579 | 96.666 | 180.513 | 175.479 | 266.971 | 220.087 |
Cash | 31.054 | 13.413 | 14.848 | 7.695 | 4.171 | 72.371 | 9.711 | 61.255 | 4.684 | 45.271 |
Shareholders Funds | 24.473 | 42.703 | 57.612 | 164.548 | 294.115 | 336.359 | 377.396 | 457.594 | 474.059 | 454.327 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 20.010 | 73.085 | 194.913 | 180.847 | 383.150 | 337.139 | 315.108 | 312.241 | 534.946 | 703.565 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "111 - 111" | |||||||||
CAEN Financial Year |
111
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Biosab Timişoara Srl